Latest Leukemia News
Non-Covalent BTK Inhibitor Approved for CLL
The FDA expanded the label of pirtobrutinib (Jaypirca) to include the treatment…
Apixaban Prophylaxis Fails to Reduce Clots in Pediatric ALL
Prophylaxis with apixaban (Eliquis) failed to reduce the rate of venous thromboembolism…
Frontline Combo Yields High Remission Rate in Hairy Cell Leukemia
Use of the BRAF inhibitor vemurafenib (Zelboraf) combined with the anti-CD20 monoclonal…
